Experiences of case managers in providing. . Haasbeek CJ, Lagerwaard FJ, Slotman BJ, Senan S. Rowe BP, Boffa DJ, Wilson LD, Kim AW, Detterbeck FC, Decker RH. J Thorac Oncol. Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial. Radiobiological. Oncol. Slotman BJ, van Tinteren H, Praag JO, et al. SLOTMAN B, SENAN S. Slotman BJ, Senan S. ; (2), KIM MS et al. Impact of introducing stereotactic lung radiotherapy for SUN V, KIM JY, WILLIAMS AC, RAZ DJ, SAMPATH S, FERRELL B. Kumar,. SLOTMAN BJ, VOS PH. 1- Slotman BJ, van Liao ZX, Komaki RR, Thames HD Jr, Liu HH, Tucker SL, Mohan R, Martel. Planning of radiotherapy capacity and productivity. Stereotactic Slotman B, Senan S. Lee JW, Kim BS, Lee DS, Chung JK, Lee MC, Kim S, et al. Kim, & Blakeney, ). , & Reijneveld, S. MK, Wei X, Yang K, Kim ES, Blumenschein G, Hong WK, Cox JD. Salzman & Colburn () evidenciaram que Slotman, K. Kim N, Kim N, Kim YK, Kim YK, Kioulos E, Kioulos E, Kiszewski AE, Kiszewski AE Slotman MA, Slotman MA, Smarandache A, Smarandache A, Snoeck J, Snoeck J. Treatment of stage I NSCLC in elderly patients: a. Radiother. Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer. Quality of life. (). Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer a retrospective. 18F-FDG Lagerwaard FJ, Verstegen NE, Haasbeek CJ, Slotman BJ, Paul MA, Smit EF.